SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-047880
Filing Date
2023-10-11
Accepted
2023-10-11 17:10:53
Documents
12
Period of Report
2023-10-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ef20012370_8k.htm   iXBRL 8-K 35150
  Complete submission text file 0001140361-23-047880.txt   176370

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ikna-20231011.xsd EX-101.SCH 3880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20231011_lab.xml EX-101.LAB 23290
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20231011_pre.xml EX-101.PRE 16562
6 EXTRACTED XBRL INSTANCE DOCUMENT ef20012370_8k_htm.xml XML 4380
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 231321297
SIC: 2836 Biological Products, (No Diagnostic Substances)